Opinion

Video

Reducing Treatment Burden in IBD with At-Home Therapy Options

Jean-Frederic Colombel, MD, offers insights into subcutaneous infliximab-dyyb injection, detailing its administration and approved indications for ulcerative colitis and Crohn's disease.

  1. The FDA has now approved a subcutaneous infliximab injection for IBD. Can you provide an overview of subcutaneous infliximab-dyyb injection? What is the significance of this approval?
    1. How could this impact patients with UC and CD?
  2. What are the indications for subcutaneous infliximab-dyyb injection?
    1. When and how can this therapy be started?
Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.